Literature DB >> 22249197

Severe asthma in childhood: recent advances in phenotyping and pathogenesis.

Anne M Fitzpatrick1, Carlos E Baena-Cagnani, Leonard B Bacharier.   

Abstract

PURPOSE OF REVIEW: Children with severe asthma have a high degree of respiratory morbidity despite treatment with high doses of inhaled corticosteroids and are therefore very difficult to treat. This review will discuss phenotypic and pathogenic aspects of severe asthma in childhood, as well as remaining knowledge gaps. RECENT
FINDINGS: As a group, children with severe asthma have a number of distinct phenotypic features compared with children with mild-to-moderate asthma. Clinically, children with severe asthma are differentiated by greater allergic sensitization, increased exhaled nitric oxide, and significant airflow limitation and air trapping that worsens as a function of age. These findings are accompanied by structural airway changes and increased and dysregulated airway inflammation and oxidant stress which may explain the differential nature of corticosteroid responsiveness in this population. Because children with severe asthma themselves are a heterogeneous group, current efforts are focused on improved definition and sub-phenotyping of the disorder. Whereas the clinical relevance of phenotyping approaches in severe asthma is not yet clear, they may provide important insight into the mechanisms underlying the disorder.
SUMMARY: Improved classification of severe asthma through unified definitions, careful phenotypic analyses, and mechanism-focused endotyping approaches may ultimately advance knowledge and personalized treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22249197      PMCID: PMC3310912          DOI: 10.1097/ACI.0b013e32835090ac

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  84 in total

Review 1.  The Melbourne Asthma Study: 1964-1999.

Authors:  Peter D Phelan; Colin F Robertson; Anthony Olinsky
Journal:  J Allergy Clin Immunol       Date:  2002-02       Impact factor: 10.793

2.  Thiol redox disturbances in children with severe asthma are associated with posttranslational modification of the transcription factor nuclear factor (erythroid-derived 2)-like 2.

Authors:  Anne M Fitzpatrick; Susan T Stephenson; Graham R Hadley; Leandrea Burwell; Madhuri Penugonda; Dawn M Simon; Jason Hansen; Dean P Jones; Lou Ann S Brown
Journal:  J Allergy Clin Immunol       Date:  2011-04-22       Impact factor: 10.793

3.  Glutathione oxidation is associated with airway macrophage functional impairment in children with severe asthma.

Authors:  Anne M Fitzpatrick; W Gerald Teague; Leandrea Burwell; Meredith S Brown; Lou Ann S Brown
Journal:  Pediatr Res       Date:  2011-02       Impact factor: 3.756

4.  The path to personalized medicine.

Authors:  Margaret A Hamburg; Francis S Collins
Journal:  N Engl J Med       Date:  2010-06-15       Impact factor: 91.245

5.  Allergy, total serum immunoglobulin E, and airflow in children and adolescents in TENOR.

Authors:  Tmirah Haselkorn; Stanley J Szefler; F E R Simons; Robert S Zeiger; David R Mink; Bradley E Chipps; Larry Borish; Dennis A Wong
Journal:  Pediatr Allergy Immunol       Date:  2010-12       Impact factor: 6.377

6.  Noneosinophilic asthma in children: relation with airway remodelling.

Authors:  S Baraldo; G Turato; E Bazzan; A Ballarin; M Damin; E Balestro; K Lokar Oliani; F Calabrese; P Maestrelli; D Snijders; A Barbato; M Saetta
Journal:  Eur Respir J       Date:  2011-02-10       Impact factor: 16.671

7.  Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone.

Authors:  D N Payne; I M Adcock; N M Wilson; T Oates; M Scallan; A Bush
Journal:  Am J Respir Crit Care Med       Date:  2001-10-15       Impact factor: 21.405

8.  Increased airway smooth muscle mass in children with asthma, cystic fibrosis, and non-cystic fibrosis bronchiectasis.

Authors:  Nicolas Regamey; Matthias Ochs; Tom N Hilliard; Christian Mühlfeld; Nikki Cornish; Louise Fleming; Sejal Saglani; Eric W F W Alton; Andrew Bush; Peter K Jeffery; Jane C Davies
Journal:  Am J Respir Crit Care Med       Date:  2008-01-24       Impact factor: 21.405

9.  Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma.

Authors:  Bradley E Chipps; Stanley J Szefler; F Estelle R Simons; Tmirah Haselkorn; David R Mink; Yamo Deniz; June H Lee
Journal:  J Allergy Clin Immunol       Date:  2007-03-30       Impact factor: 10.793

10.  Levels of nitric oxide oxidation products are increased in the epithelial lining fluid of children with persistent asthma.

Authors:  Anne M Fitzpatrick; Lou Ann S Brown; Fernando Holguin; W Gerald Teague
Journal:  J Allergy Clin Immunol       Date:  2009-11       Impact factor: 10.793

View more
  7 in total

1.  Atopic phenotypes identified with latent class analyses at age 2 years.

Authors:  Suzanne Havstad; Christine Cole Johnson; Haejin Kim; Albert M Levin; Edward M Zoratti; Christine L M Joseph; Dennis R Ownby; Ganesa Wegienka
Journal:  J Allergy Clin Immunol       Date:  2014-03-15       Impact factor: 10.793

2.  High IFN-γ and low SLPI mark severe asthma in mice and humans.

Authors:  Mahesh Raundhal; Christina Morse; Anupriya Khare; Timothy B Oriss; Jadranka Milosevic; John Trudeau; Rachael Huff; Joseph Pilewski; Fernando Holguin; Jay Kolls; Sally Wenzel; Prabir Ray; Anuradha Ray
Journal:  J Clin Invest       Date:  2015-06-29       Impact factor: 14.808

Review 3.  Current concepts of severe asthma.

Authors:  Anuradha Ray; Mahesh Raundhal; Timothy B Oriss; Prabir Ray; Sally E Wenzel
Journal:  J Clin Invest       Date:  2016-07-01       Impact factor: 14.808

4.  Phenotypes and endotypes of severe asthma in children.

Authors:  Young Yoo
Journal:  Korean J Pediatr       Date:  2013-05-28

5.  Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma.

Authors:  Steven W Yancey; Hector G Ortega; Oliver N Keene; Eric S Bradford
Journal:  Allergy Asthma Clin Immunol       Date:  2019-09-03       Impact factor: 3.406

6.  High-Flow Nasal Cannula: A Promising Oxygen Therapy for Patients with Severe Bronchial Asthma Complicated with Respiratory Failure.

Authors:  Wanru Geng; Wuliji Batu; Shuhong You; Zhaohui Tong; Hangyong He
Journal:  Can Respir J       Date:  2020-02-20       Impact factor: 2.409

Review 7.  Insights Into Type I and III Interferons in Asthma and Exacerbations.

Authors:  Helen E Rich; Danielle Antos; Natalie R Melton; John F Alcorn; Michelle L Manni
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.